切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2026, Vol. 12 ›› Issue (03) : 235 -251. doi: 10.3877/cma.j.issn.2096-1537.2026.03.002

专家共识

重症医学人工智能临床应用与治理专家共识
中国医师协会重症医学医师分会专家委员会   
  • 收稿日期:2026-07-31 出版日期:2026-08-28

Expert consensus on clinical application and governance of artificial intelligence in critical care medicine

Expert Committee of the Critical Care Medicine Branch, Chinese Medical Doctor Association   

  • Received:2026-07-31 Published:2026-08-28
引用本文:

中国医师协会重症医学医师分会专家委员会. 重症医学人工智能临床应用与治理专家共识[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 235-251.

Expert Committee of the Critical Care Medicine Branch, Chinese Medical Doctor Association. Expert consensus on clinical application and governance of artificial intelligence in critical care medicine[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2026, 12(03): 235-251.

人工智能(AI)正在由模型研究逐步进入重症医学临床实践。重症诊疗环境具有患者病情变化快、连续监测数据密集、多器官功能相互影响、治疗干预频繁和生命支持设备高度参与等特点,既为AI提供了重要应用场景,也使错误输出可能迅速影响临床判断和患者安全。为促进AI在我国重症医学领域安全、有效和规范应用,本共识制定专家组基于国内外文献、规范性文件和我国重症医学实践,采用改良德尔菲法形成推荐意见。共识围绕重症AI的定义与定位、风险分级、临床应用场景、连续监测与报警管理、治疗决策支持、人机协同、数据治理、模型开发与评价、真实临床环境运行、人员培训、隐私安全、公平性、持续监测及新兴技术边界等方面,共形成16条推荐意见,并强调重症AI应定位为医务人员的辅助工具,其评价不应局限于离线模型性能,还应关注预测时间窗、有效提前时间、报警负担、人机协同、安全事件及患者结局等。相关推荐可为医疗机构开展重症AI系统的研发评价、临床准入、实际应用和持续治理提供参考,并为临床医务人员、医疗机构管理者、技术研发团队及相关政策制定者规范应用重症AI提供依据。

Artificial intelligence (AI) is transitioning from model development to clinical practice in critical care medicine. Critical care is characterized by rapidly changing patient conditions, dense streams of continuous monitoring data, interactions among multiple organ systems, frequent therapeutic interventions, and extensive reliance on life-support technologies. These features create important opportunities for AI but also increase the risk that erroneous outputs may rapidly affect clinical judgment and patient safety. To promote the safe, effective, and standardized use of AI in critical care medicine in China, the consensus panel formulated recommendations using a modified Delphi method, informed by domestic and international literature, relevant policy and guidance documents, and current critical care practice. The consensus comprises 16 recommendations covering the definition and role of AI in critical care, risk classification, clinical applications, continuous monitoring and alarm management, treatment decision support, human–AI collaboration, data governance, model development and evaluation, operation in real-world clinical settings, personnel training, privacy and security, fairness, post-deployment monitoring, and the boundaries of emerging technologies. It emphasizes that AI in critical care should support, rather than replace, healthcare professionals. Evaluation should extend beyond offline model performance to include the prediction horizon, actionable lead time, alarm burden, human–AI collaboration, safety events, and patient outcomes. These recommendations are intended to support healthcare institutions in developing and evaluating AI systems, authorizing them for clinical use, implementing them in practice, and governing them throughout their life cycle. They also provide guidance for healthcare professionals, healthcare administrators, technology developers, and policymakers on the appropriate and standardized use of AI in critical care.

表1 重症AI应用风险分级及准入管理建议(参考IMDRF SaMD风险分类框架[96])
1
Loriga B, Baglivo F, Bellini V, et al. Top three priorities for artificial intelligence integration into emergency, critical, and perioperative medicine: an interdisciplinary clinical expert consensus[J]. J Anesth Analg Crit Care, 2025, 5(1): 77.
2
Cecconi M, Greco M, Shickel B, et al. Implementing artificial intelligence in critical care medicine: a consensus of 22[J]. Crit Care, 2025, 29(1): 290.
3
Adams R, Henry KE, Sridharan A, et al. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis[J]. Nat Med, 2022, 28(7): 1455-1460.
4
Persson I, Macura A, Becedas D, et al. Early prediction of sepsis in intensive care patients using the machine learning algorithm NAVOY® Sepsis, a prospective randomized clinical validation study[J]. J Crit Care, 2024, 80: 154400.
5
Workum JD, Volkers B, van de Sande D, et al. Comparative evaluation and performance of large language models on expert level critical care questions: a benchmark study[J]. Crit Care, 2025, 29(1): 72.
6
Bhargava A, López-Espina C, Schmalz L, et al. FDA-authorized AI/ML tool for sepsis prediction: development and validation[J]. NEJM AI, 2024, 1(12): AIoa2400867.
7
Hyland SL, Faltys M, Hüser M, et al. Early prediction of circulatory failure in the intensive care unit using machine learning[J]. Nat Med, 2020, 26(3): 364-373.
8
Tomašev N, Glorot X, Rae JW, et al. A clinically applicable approach to continuous prediction of future acute kidney injury[J]. Nature, 2019, 572(7767): 116-119.
9
Lee KH, Yoon D, Lim H, et al. Deep learning models for acute kidney injury prediction: multi-center external validation and evaluation under simulated continuous monitoring conditions[J]. NPJ Digit Med, 2026, 9(1): 544.
10
Fleuren LM, Klausch T, Zwager CL, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy[J]. Intensive Care Med, 2020, 46(3): 383-400.
11
Zubair M, Din I, Sarwar N, et al. Revolutionizing sepsis diagnosis using machine learning and deep learning models: a systematic literature review[J]. BMC Infect Dis, 2025, 25(1): 1396.
12
Wong A, Otles E, Donnelly JP, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients[J]. JAMA Intern Med, 2021, 181(8): 1065-1070.
13
Rubulotta F, Bahrami S, Marshall DC, et al. Machine learning tools for acute respiratory distress syndrome detection and prediction[J]. Crit Care Med, 2024, 52(11): 1768-1780.
14
Levy E, Claar D, Co I, et al. Development and external validation of a detection model to retrospectively identify patients with acute respiratory distress syndrome[J]. Crit Care Med, 2025, 53(6): e1224-e1234.
15
Wilson FP, Martin M, Yamamoto Y, et al. Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial[J]. BMJ, 2021, 372: m4786.
16
Li T, Wu B, Li L, et al. Automated electronic alert for the care and outcomes of adults with acute kidney injury: a randomized clinical trial[J]. JAMA Netw Open, 2024, 7(1): e2351710.
17
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
18
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-c184.
19
Matthay MA, Arabi Y, Arroliga AC, et al. A new global definition of acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2024, 209(1): 37-47.
20
Grasselli G, Calfee CS, Camporota L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies[J]. Intensive Care Med, 2023, 49(7): 727-759.
21
Chen HB, Xu AM, Qiu HB, et al. Single-cell sequencing redefines immune heterogeneity and communication networks in ARDS: toward precision therapeutics[J]. Int J Genomics, 2025, 2025: 9902676.
22
van Amstel R, Kennedy JN, Scicluna BP, et al. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes[J]. Intensive Care Med, 2023, 49(11): 1360-1369.
23
Sinha P, Kerchberger VE, Willmore A, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials[J]. Lancet Respir Med, 2023, 11(11): 965-974.
24
Chenoweth JG, Colantuoni C, Striegel DA, et al. Gene expression signatures in blood from a West African sepsis cohort define host response phenotypes[J]. Nat Commun, 2024, 15(1): 4606.
25
Bhavani SV, Spicer A, Sinha P, et al. Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories[J]. Intensive Care Med, 2024, 50(12): 2094-2104.
26
Antcliffe DB, Peronnet E, Pène F, et al. An international observational study validating gene-expression sepsis immune subgroups[J]. Crit Care, 2025, 29(1): 98.
27
Yoon CH, Sjöholm D, Wickstrøm KE, et al. Multicenter validation of clinical sepsis phenotypes[J]. JAMA Network Open, 2026, 9(6): e2616134.
28
Cajander S, Kox M, Scicluna BP, et al. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine[J]. Lancet Respir Med, 2024, 12(4): 305-322.
29
Antcliffe DB, Burrell A, Boyle AJ, et al. Sepsis subphenotypes, theragnostics and personalized sepsis care[J]. Intensive Care Med, 2025, 51(4): 756-768.
30
Slim MA, van Amstel R, Bos L, et al. Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study[J]. Crit Care, 2024, 28(1): 151.
31
Blot PL, Chousterman BG, Santafè M, et al. Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen[J]. Crit Care, 2023, 27(1): 419.
32
Fosset M, von Wedel D, Redaelli S, et al. Subphenotyping prone position responders with machine learning[J]. Crit Care, 2025, 29(1): 116.
33
Pensier J, Fosset M, Paschold BS, et al. Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality[J]. Intensive Care Med, 2025, 51(10): 1784-1796.
34
van Amstel R, Bartek B, Vlaar A, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness[J]. Am J Respir Crit Care Med, 2025, 211(3): 347-356.
35
Reddy K, Sinha P, O'Kane CM, et al. Subphenotypes in critical care: translation into clinical practice[J]. Lancet Respir Med, 2020, 8(6): 631-643.
36
Files DC, Matthay MA, Chapple AG, et al. Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study[J]. Lancet Respir Med, 2026, 14(7): 601-608.
37
Bhatraju PK, Prince DK, Mansour S, et al. Integrated analysis of blood and urine biomarkers to identify acute kidney injury subphenotypes and associations with long-term outcomes[J]. Am J Kidney Dis, 2023, 82(3): 311-321.e1.
38
Stanski NL, Zhang B, Ouyang J, et al. External validation, molecular signatures, and therapeutic relevance of pediatric sepsis-associated acute kidney injury subphenotypes[J]. Crit Care Med, 2026, 54(7): 1680-1690.
39
Legrand M, Bagshaw SM, Bhatraju PK, et al. Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials[J]. Crit Care, 2024, 28(1): 92.
40
Munroe ES, Spicer A, Castellvi-Font A, et al. Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill[J]. Lancet Respir Med, 2025, 13(6): 556-568.
41
Shankar-Hari M, Calandra T, Soares MP, et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies[J]. Lancet Respir Med, 2024, 12(4): 323-336.
42
Komorowski M, Celi LA, Badawi O, et al. The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care[J]. Nat Med, 2018, 24(11): 1716-1720.
43
Gottesman O, Johansson F, Komorowski M, et al. Guidelines for reinforcement learning in healthcare[J]. Nat Med, 2019, 25(1): 16-18.
44
Kalimouttou A, Kennedy JN, Feng J, et al. Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study[J]. JAMA, 2025, 333(19): 1688-1698.
45
Hayasaka T, Nakane M, Fujiwara Y, et al. Development of a deep-learning model for classification of intensivists' extubation decisions using ventilator graphic monitor images: a prospective observational study[J]. J Intensive Care, 2026, 14(1): 56.
46
Goldschmidt E, Rannon E, Bernstein D, et al. Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection[J]. NPJ Digit Med, 2025, 8(1): 87.
47
Tang Z, Sun P, Liang R, et al. Reinforcement learning for treatment decision-making in sepsis: a scoping review[J]. NPJ Digit Med, 2026. Online ahead of print.
48
Nauka PC, Kennedy JN, Brant EB, et al. Challenges with reinforcement learning model transportability for sepsis treatment in emergency care[J]. NPJ Digit Med, 2025, 8(1): 91.
49
张玉雯, 白颖璐, 张学敏, 等. 人工智能技术在脓毒症患者诊断与治疗中应用的研究进展[J]. 中华烧伤与创面修复杂志, 2025, 41(10): 998-1003.
50
Lewandowska K, Mędrzycka-Dąbrowska W, Mikłas M, et al. Improving alarm management to reduce alarm fatigue in critical care: a mixed-methods study[J]. Intensive Crit Care Nurs, 2026, 93: 104254.
51
Movahedi A, Sadooghiasl A, Ahmadi F, et al. A grounded theory study of alarm fatigue among nurses in intensive care units[J]. Aust Crit Care, 2023, 36(6): 980-988.
52
Gul G, Intepeler SS, Bektas M. The effect of interventions made in intensive care units to reduce alarms: a systematic review and meta-analysis study[J]. Intensive Crit Care Nurs, 2023, 75: 103375.
53
Nyarko BA, Nie H, Yin Z, et al. The effect of educational interventions in managing nurses' alarm fatigue: an integrative review[J]. J Clin Nurs, 2023, 32(13-14): 2985-2997.
54
Li B, Yue L, Nie H, et al. The effect of intelligent management interventions in intensive care units to reduce false alarms: an integrative review[J]. Int J Nurs Sci, 2024, 11(1): 133-142.
55
Lilly CM, Kirk D, Pessach IM, et al. Application of machine learning models to biomedical and information system signals from critically ill adults[J]. Chest, 2024, 165(5): 1139-1148.
56
Ouyang D, He B, Ghorbani A, et al. Video-based AI for beat-to-beat assessment of cardiac function[J]. Nature, 2020, 580(7802): 252-256.
57
He B, Kwan AC, Cho JH, et al. Blinded, randomized trial of sonographer versus AI cardiac function assessment[J]. Nature, 2023, 616(7957): 520-524.
58
Narang A, Bae R, Hong H, et al. Utility of a deep-learning algorithm to guide novices to acquire echocardiograms for limited diagnostic use[J]. JAMA Cardiol, 2021, 6(6): 624-632.
59
Tromp J, Bauer D, Claggett BL, et al. A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram[J]. Nat Commun, 2022, 13(1): 6776.
60
Moore CL, Wang J, Battisti AJ, et al. Interobserver agreement and correlation of an automated algorithm for b-line identification and quantification with expert sonologist review in a handheld ultrasound device[J]. J Ultrasound Med, 2022, 41(10): 2487-2495.
61
Chiu IM, Chen TY, Zheng YC, et al. Prospective clinical evaluation of deep learning for ultrasonographic screening of abdominal aortic aneurysms[J]. NPJ Digit Med, 2024, 7(1): 282.
62
Clinical and Laboratory Standards Institute. Autoverification of clinical laboratory test results; approved guideline[S]. CLSI document AUTO10-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.
63
Wang H, Wang H, Zhang J, et al. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory[J]. Clin Chem Lab Med, 2021, 59(5): 883-891.
64
Wang Z, Peng C, Kang H, et al. Design and evaluation of a LISbased autoverification system for coagulation assays in a core clinical laboratory[J]. BMC Med Inform Decis Mak, 2019, 19(1): 123.
65
Yao X, Rushlow DR, Inselman JW, et al. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial[J]. Nat Med, 2021, 27(5): 815-819.
66
Bergin SP, Chemaly RF, Dadwal SS, et al. Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study[J]. Clin Infect Dis, 2024, 78(3): 775-784.
67
Han D, Yu F, Zhang D, et al. Molecular rapid diagnostic testing for bloodstream infections: nanopore targeted sequencing with pathogen-specific primers[J]. J Infect, 2024, 88(6): 106166.
68
Liu PY, Wu HC, Li YL, et al. Comprehensive pathogen identification and antimicrobial resistance prediction from positive blood cultures using nanopore sequencing technology[J]. Genome Med, 2024, 16(1): 141.
69
Nguyen HA, Peleg AY, Song J, et al. Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra[J]. mSystems, 2024, 9(9): e0078924.
70
Wiesmann N, Enders D, Westendorf A, et al. Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study[J]. J Clin Microbiol, 2025, 63(12): e0118625.
71
Walter C, Weissert C, Gizewski E, et al. Performance evaluation of machine-assisted interpretation of Gram stains from positive blood cultures[J]. J Clin Microbiol, 2024, 62(4): e0087623.
72
McMahon J, Tomita N, Tatishev ES, et al. A novel framework for the automated characterization of Gram-stained blood culture slides using a large-scale vision transformer[J]. J Clin Microbiol, 2025, 63(3): e0151424.
73
Pereira AJ, Noritomi DT, Dos Santos MC, et al. Effect of Tele-ICU on clinical outcomes of critically ill patients: the TELESCOPE randomized clinical trial[J]. JAMA, 2024, 332(21): 1798-1807.
74
Midega TD, Hohmann FB, Chaves R, et al. Impact of Tele-intensive care units on the clinical outcomes of critically ill patients with COVID-19: retrospective cohort study[J]. J Med Internet Res, 2026, 28: e64996.
75
Hidalgo EM, Wright L, Isaksson M, et al. Current applications of robot-assisted ultrasound examination[J]. JACC Cardiovasc Imaging, 2023, 16(2): 239-247.
76
Song J, Sridhar RI, Rogers DM, et al. Clinicians' perceptions and potential applications of robotics for task automation in critical care: qualitative study[J]. J Med Internet Res, 2025, 27: e62957.
77
周飞虎, 毛智. 智慧化重症监护病房建设与重症烧伤治疗: 融合创新[J]. 中华烧伤与创面修复杂志, 2025, 41(9): 840-846.
78
Marcus HJ, Ramirez PT, Khan DZ, et al. The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring[J]. Nat Med, 2024, 30(1): 61-75.
79
Mir BA, Nishwa DE, Lee SW. Embodied artificial intelligence in healthcare: a systematic review of robotic perception, decision-making, and clinical impact[J]. Healthcare (Basel), 2026, 14(5): 572.
80
Van De Sande D, Van Genderen ME, Huiskens J, et al. Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit[J]. Intensive Care Med, 2021, 47(7): 750-760.
81
Plana D, Shung DL, Grimshaw AA, et al. Randomized clinical trials of machine learning interventions in health care: a systematic review[J]. JAMA Netw Open, 2022, 5(9): e2233946.
82
Han R, Acosta JN, Shakeri Z, et al. Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review[J]. Lancet Digit Health, 2024, 6(5): e367-e373.
83
Lyons PG, Hofford MR, Yu SC, et al. Factors associated with variability in the performance of a proprietary sepsis prediction model across 9 networked hospitals in the US[J]. JAMA Intern Med, 2023, 183(6): 611-612.
84
Boussina A, Shashikumar SP, Malhotra A, et al. Impact of a deep learning sepsis prediction model on quality of care and survival[J]. NPJ Digit Med, 2024, 7(1): 14.
85
Bedoya AD, Clement ME, Phelan M, et al. Minimal impact of implemented early warning score and best practice alert for patient deterioration[J]. Crit Care Med, 2019, 47(1): 49-55.
86
Wijnberge M, Geerts BF, Hol L, et al. Effect of a machine learning-derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial[J]. JAMA, 2020, 323(11): 1052-1060.
87
Khwannimit B, Sathaporn N, Vattanavanit V. Ability of the hypotension prediction index to predict hypotension in patients with septic shock in the intensive care unit[J]. Sci Rep, 2025, 15(1): 40478.
88
Zarantonello F, De Cassai A, Pettenuzzo T, et al. Artificial intelligence in intensive care units: a scoping review addressing the translational gap to clinical practice[J]. Korean J Anesthesiol, 2026, 79(3): 291-305.
89
Shillan D, Sterne J, Champneys A, et al. Use of machine learning to analyse routinely collected intensive care unit data: a systematic review[J]. Crit Care, 2019, 23(1): 284.
90
Pinsky MR, Bedoya A, Bihorac A, et al. Use of artificial intelligence in critical care: opportunities and obstacles[J]. Crit Care, 2024, 28(1): 113.
91
Yoon JH, Pinsky MR, Clermont G. Artificial intelligence in critical care medicine[J]. Crit Care, 2022, 26(1): 75.
92
Lekadir K, Frangi AF, Porras AR, et al. FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare[J]. BMJ, 2025, 388: e081554.
93
World Health Organization. Ethics and governance of artificial intelligence for health: WHO guidance[R]. Geneva, Switzerland: World Health Organization, 2021.
94
World Health Organization. Regulatory considerations on artificial intelligence for health[R]. Geneva, Switzerland: World Health Organization, 2023.
95
U.S. Food and Drug Administration. Good machine learning practice for medical device development: Guiding principles [EB/OL]. (2025-12-19) [2026-07-20].
96
International Medical Device Regulators Forum. Software as a medical device: possible framework for risk categorization and corresponding considerations[R]. Geneva, Switzerland: International Medical Device Regulators Forum, 2014.
97
国家药品监督管理局医疗器械技术审评中心. 人工智能医疗器械注册审查指导原则 [EB/OL]. (2022-03-07) [2026-07-20].
98
国家卫生健康委员会办公厅, 国家中医药局综合司, 国家疾控局综合司. 卫生健康行业人工智能应用场景参考指引 [EB/OL]. (2024-11-06)[2026-7-20].
99
国家卫生健康委办公厅, 国家发展改革委办公厅, 工业和信息化部办公厅, 等. 关于促进和规范“人工智能+医疗卫生”应用发展的实施意见 [EB/OL]. (2025-10-20) [2026-07-20].
100
U.S. Food and Drug Administration, Health Canada, United Kingdom's Medicines and Healthcare Products Regulatory Agency. Transparency for machine learning-enabled medical devices: Guiding principles [EB/OL]. (2024-06-13) [2026-7-20].
101
European Parliament and of the Council. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act)[R]. Off J Eur Union, 2024, L 2024/1689.
102
Johnson A, Bulgarelli L, Shen L, et al. MIMIC-Ⅳ, a freely accessible electronic health record dataset[J]. Sci Data, 2023, 10(1): 1.
103
Pollard TJ, Johnson A, Raffa JD, et al. The eICU collaborative research database, a freely available multi-center database for critical care research[J]. Sci Data, 2018, 5: 180178.
104
Thoral PJ, Peppink JM, Driessen RH, et al. Sharing ICU patient data responsibly under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: the Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example[J]. Crit Care Med, 2021, 49(6): e563-e577.
105
Faltys M, Zimmermann M, Lyu X, et al. HiRID, a high time-resolution ICU dataset[DS/OL]. (2021-02-18) [2026-7-20].
106
Sauer CM, Dam TA, Celi LA, et al. Systematic review and comparison of publicly available ICU data sets-a decision guide for clinicians and data scientists[J]. Crit Care Med, 2022, 50(6): e581-e588.
107
Harutyunyan H, Khachatrian H, Kale DC, et al. Multitask learning and benchmarking with clinical time series data[J]. Sci Data, 2019, 6(1): 96.
108
Wang S, Mcdermott MBA, Chauhan G, et al. MIMIC-extract: a data extraction, preprocessing, and representation pipeline for MIMIC-Ⅲ[C]// Proceedings of the ACM Conference on Health, Inference, and Learning. Toronto, ON, Canada: ACM, 2020: 222-235.
109
Bennett N, Plečko D, Ukor IF, Meinshausen N, Bühlmann P. ricu: R's interface to intensive care data[J]. Gigascience, 2022, 12: giad041.
110
Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research[J]. J Am Med Inform Assoc, 2013, 20(1): 144-151.
111
Davis SE, Matheny ME, Balu S, et al. A framework for understanding label leakage in machine learning for health care[J]. J Am Med Inform Assoc, 2023, 31(1): 274-280.
112
Kapoor S, Narayanan A. Leakage and the reproducibility crisis in machine-learning-based science[J]. Patterns (N Y), 2023, 4(9): 100804.
113
Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship[J]. Sci Data, 2016, 3: 160018.
114
Collins GS, Moons K, Dhiman P, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods[J]. BMJ, 2024, 385: e078378.
115
Moons K, Damen J, Kaul T, et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods[J]. BMJ, 2025, 388: e082505.
116
Vasey B, Nagendran M, Campbell B, et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI[J]. Nat Med, 2022, 28(5): 924-933.
117
Liu X, Cruz Rivera S, Moher D, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension[J]. Nat Med, 2020, 26(9): 1364-1374.
118
Cruz Rivera S, Liu X, Chan AW, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension[J]. Nat Med, 2020, 26(9): 1351-1363.
119
Norgeot B, Quer G, Beaulieu-Jones BK, et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist[J]. Nat Med, 2020, 26(9): 1320-1324.
120
Shi T, Lin Y, Zhao H, et al. Artificial intelligence models for predicting acute kidney injury in the intensive care unit: a systematic review of modeling methods, data utilization, and clinical applicability[J]. JAMIA Open, 2025, 8(4): ooaf065.
121
Tran TK, Tran MC, Joseph A, et al. A systematic review of machine learning models for management, prediction and classification of ARDS[J]. Respir Res, 2024, 25(1): 232.
122
You JG, Hernandez-Boussard T, Pfeffer MA, et al. Clinical trials informed framework for real world clinical implementation and deployment of artificial intelligence applications[J]. NPJ Digit Med, 2025, 8(1): 107.
123
van der Vegt AH, Scott IA, Dermawan K, et al. Implementation frameworks for end-to-end clinical AI: derivation of the SALIENT framework[J]. J Am Med Inform Assoc, 2023, 30(9): 1503-1515.
124
Gama F, Tyskbo D, Nygren J, et al. Implementation frameworks for artificial intelligence translation into health care practice: scoping review[J]. J Med Internet Res, 2022, 24(1): e32215.
125
Reddy S, Rogers W, Makinen VP, et al. Evaluation framework to guide implementation of AI systems into healthcare settings[J]. BMJ Health Care Inform, 2021, 28(1): e100444.
126
Yang J, Soltan A, Clifton DA. Machine learning generalizability across healthcare settings: insights from multi-site COVID-19 screening[J]. NPJ Digit Med, 2022, 5(1): 69.
127
Peek N, Capurro D, Rozova V, et al. Bridging the gap: challenges and strategies for the implementation of artificial intelligence-based clinical decision support systems in clinical practice[J]. Yearb Med Inform, 2024, 33(1): 103-114.
128
Bizzo BC, Dasegowda G, Bridge C, et al. Addressing the challenges of implementing artificial intelligence tools in clinical practice: principles from experience[J]. J Am Coll Radiol, 2023, 20(3): 352-360.
129
van der Vegt AH, Scott IA, Dermawan K, et al. Deployment of machine learning algorithms to predict sepsis: systematic review and application of the SALIENT clinical AI implementation framework[J]. J Am Med Inform Assoc, 2023, 30(7): 1349-1361.
130
Hellmeier F, Brosien K, Eickhoff C, et al. Beyond one-time validation: a framework for adaptive validation of prognostic and diagnostic AI-based medical devices [EB/OL]. (2024-09-07) [2026-7-20].
131
El Arab RA, Abu-Mahfouz MS, Abuadas FH, et al. Bridging the gap: from AI success in clinical trials to real-world healthcare implementation—a narrative review[J]. Healthcare, 2025, 13(7): 701.
132
Riley RD, Snell K, Archer L, et al. Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study[J]. BMJ, 2024, 384: e074821.
133
Daye D, Wiggins WF, Lungren MP, et al. Implementation of clinical artificial intelligence in radiology: who decides and how?[J]. Radiology, 2022, 305(3): 555-563.
134
Ibrahim H, Liu X, Rivera SC, et al. Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines[J]. Trials, 2021, 22(1): 11.
135
Corbin CK, Maclay R, Acharya A, et al. DEPLOYR: a technical framework for deploying custom real-time machine learning models into the electronic medical record[J]. J Am Med Inform Assoc, 2023, 30(9): 1532-1542.
136
Boss JM, Narula G, Straessle C, et al. ICU cockpit: a platform for collecting multimodal waveform data, AI-based computational disease modeling and real-time decision support in the intensive care unit[J]. J Am Med Inform Assoc, 2022, 29(7): 1286-1291.
137
Drew BJ, Harris P, Zègre-Hemsey JK, et al. Insights into the problem of alarm fatigue with physiologic monitor devices: a comprehensive observational study of consecutive intensive care unit patients[J]. PLoS One, 2014, 9(10): e110274.
138
Davis SE, Lasko TA, Chen G, et al. Calibration drift in regression and machine learning models for acute kidney injury[J]. J Am Med Inform Assoc, 2017, 24(6): 1052-1061.
139
Davis SE, Greevy RA, Lasko TA, et al. Detection of calibration drift in clinical prediction models to inform model updating[J]. J Biomed Inform, 2020, 112: 103611.
140
Finlayson SG, Subbaswamy A, Singh K, et al. The clinician and dataset shift in artificial intelligence[J]. N Engl J Med, 2021, 385(3): 283-286.
141
U.S. Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions; Guidance for Industry and Food and Drug Administration Staff; Availability[R]. Fed Regist, 2024, 89(233): 96259-96261.
142
Obermeyer Z, Powers B, Vogeli C, et al. Dissecting racial bias in an algorithm used to manage the health of populations[J]. Science, 2019, 366(6464): 447-453.
143
Liu X, Liu H, Yang G, et al. A generalist medical language model for disease diagnosis assistance[J]. Nat Med, 2025, 31(3): 932-942.
144
Shashikumar SP, Mohammadi S, Krishnamoorthy R, et al. Development and prospective implementation of a large language model based system for early sepsis prediction[J]. NPJ Digit Med, 2025, 8(1): 290.
145
Idan D, Einav S. Primer on large language models: an educational overview for intensivists[J]. Crit Care, 2025, 29(1): 238.
146
Moritz M, Topol E, Rajpurkar P. Coordinated AI agents for advancing healthcare[J]. Nat Biomed Eng, 2025, 9(4): 432-438.
147
Chen X, Yi H, You M, et al. Enhancing diagnostic capability with multi-agents conversational large language models[J]. NPJ Digit Med, 2025, 8(1): 159.
148
Wang S, Zhao F, Bu D, et al. LINS: a general medical Q&A framework for enhancing the quality and credibility of LLM-generated responses[J]. Nat Commun, 2025, 16(1): 9076.
149
De Domenico M, Allegri L, Caldarelli G, et al. Challenges and opportunities for digital twins in precision medicine from a complex systems perspective[J]. NPJ Digit Med, 2025, 8(1): 37.
150
Iqbal JD, Krauthammer M, Witt CM, et al. A consensus statement on the use of digital twins in medicine[J]. NPJ Digit Med, 2025, 8(1): 484.
151
Akbarialiabad H, Pasdar A, Murrell DF, et al. Enhancing randomized clinical trials with digital twins[J]. NPJ Syst Biol Appl, 2025, 11(1): 110.
152
Coveney P, Highfield R, Stahlberg E, et al. Digital twins and big AI: the future of truly individualised healthcare[J]. NPJ Digit Med, 2025, 8(1): 494.
153
Makarov N, Bordukova M, Quengdaeng P, et al. Large language models forecast patient health trajectories enabling digital twins[J]. NPJ Digit Med, 2025, 8(1): 588.
154
Gu F, Meyer AJ, Ježek F, et al. Identification of digital twins to guide interpretable AI for diagnosis and prognosis in heart failure[J]. NPJ Digit Med, 2025, 8(1): 110.
155
郝辰肖, 安友仲, 赵慧颖. 脓毒症亚型与精准治疗:进展和趋势[J/OL]. 中华重症医学电子杂志, 2022, 8(2): 105-109.
156
Kelly CJ, Karthikesalingam A, Suleyman M, et al. Key challenges for delivering clinical impact with artificial intelligence[J]. BMC Med, 2019, 17(1): 195.
157
Shaw J, Rudzicz F, Jamieson T, et al. Artificial intelligence and the implementation challenge[J]. J Med Internet Res, 2019, 21(7): e13659.
158
Goddard K, Roudsari A, Wyatt JC. Automation bias: a systematic review of frequency, effect mediators, and mitigators[J]. J Am Med Inform Assoc, 2012, 19(1): 121-127.
159
Gaube S, Suresh H, Raue M, et al. Do as AI say: susceptibility in deployment of clinical decision-aids[J]. NPJ Digit Med, 2021, 4(1): 31.
[1] 李珂, 张译尹, 杨后圃, 王殊. 乳腺癌保留乳房手术中精准定位与切缘评估技术的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(05): 272-278.
[2] 郑民华, 李树春, 马君俊. 数字人工智能在直肠癌微创外科的发展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 511-515.
[3] 晏阳, 谢天宇, 杜晓辉. 智能化在直肠癌微创外科的实践[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 516-519.
[4] 方振, 商亮, 李乐平. 智能化与个体化在直肠癌微创外科的应用[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 520-523.
[5] 蔡泽荣, 兰平, 吴小剑. 数字智能化在右半结肠癌微创外科的发展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 409-413.
[6] 燕速, 何坤山, 谢宏宇, 霍博文, 刘云荣, 李园园. 智能化与个体化在右半结肠癌微创外科的应用[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 414-419.
[7] 国产腔镜手术机器人系统的临床应用解决方案研究项目专家组. 单孔机器人肾上腺切除术专家共识[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 491-497.
[8] 朱洪浩, 邢晨, 张少玲, 江春, 范新祥, 董文, 孔坚秋. 人工智能在肾上腺肿瘤诊疗中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 581-587.
[9] 王洪武. 从"以术为中心"到"以人为核心":ERAS理念引领支气管镜检查的范式革命[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 717-720.
[10] 张燚, 寇贤帅, 饶旭, 贺斌峰. 人工智能在慢性阻塞性肺疾病诊断与管理中的应用研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 882-887.
[11] 马煜博, 李起, 耿智敏. 胆道恶性肿瘤预后预测模型:现状、挑战与未来展望[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 702-710.
[12] 中国抗癌协会大肠癌专业委员会, 中国抗癌协会大肠癌专业委员会NOSES技术推广专家委员会, 海峡两岸医药卫生交流协会肿瘤学分会日间手术学组. 结直肠癌日间手术专家共识(2026版)[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(05): 385-394.
[13] 中国抗癌协会大肠癌专业委员会. 结直肠癌手术肠管切割吻合及重建的吻合器应用规范与专家共识(2026版)[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(05): 395-402.
[14] 林静, 侯世会, 王佳丽, 甘宏博, 封蕾, 李民, 陈客宏. 生成式人工智能支持的纠错式案例教学在肾内科实习中的应用[J/OL]. 中华肾病研究电子杂志, 2026, 15(05): 280-285.
[15] 陈勇, 彭淼, 裴月红, 黄骁, 张淦, 王文景, 杨琼. 《急性缺血性卒中血管内治疗技术中国专家共识2025》述评:迈向精准化与规范化[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(05): 485-490.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?